Non-Linear Mixed Effects Modeling ??? From Methodology and Software Development to Driving Implementation in Drug Development Science, Journal of Pharmacokinetics and Pharmacodynamics, vol.72, issue.6, pp.161-183, 2005. ,
DOI : 10.1007/s10928-005-0062-y
Convergence of a stochastic approximation version of EM algorithm, Ann Stat, vol.27, pp.94-128, 1999. ,
The SAEM algorithm for group comparison tests in longitudinal data analysis based on non-linear mixed-effects model, Statistics in Medicine, vol.13, issue.27, pp.4860-4875, 2007. ,
DOI : 10.1002/sim.2950
URL : https://hal.archives-ouvertes.fr/hal-00263511
Permutation theory in the derivation of robust criteria and the study of departures from assumption, J R Stat Soc Ser B Meth, vol.17, pp.1-34, 1955. ,
Ways to fit a PK model with some data below the quantification limit, Journal of Pharmacokinetics and Pharmacodynamics, vol.28, issue.5, pp.481-504, 2001. ,
DOI : 10.1023/A:1012299115260
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study, The Lancet, vol.359, issue.9300, pp.30-36, 2002. ,
DOI : 10.1016/S0140-6736(02)07276-8
Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patients, British Journal of Clinical Pharmacology, vol.58, issue.3, pp.353-362, 2007. ,
DOI : 10.1111/j.1742-7843.2006.pto_249.x
MDR1 Genotype-Related Pharmacokinetics and Pharmacodynamics, Biological & Pharmaceutical Bulletin, vol.25, issue.11, pp.1391-1400, 2002. ,
DOI : 10.1248/bpb.25.1391
Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance, Clinical Pharmacology & Therapeutics, vol.75, issue.1, pp.13-33, 2003. ,
DOI : 10.1016/j.clpt.2003.09.012
Clinical Epidemiology. A basic Science for Clinical Medecine Little Brown, Boston, vol.2, 1991. ,
Diagnosing Model Diagnostics, Clinical Pharmacology & Therapeutics, vol.23, issue.1, pp.17-20, 2007. ,
DOI : 10.1038/sj.clpt.6100241
The Bayesian Choice. A Decision-Theoretic Motivation, 1994. ,
Linear Mixed Models for Longitudinal Data, 2000. ,
DOI : 10.1007/978-1-4612-2294-1_3
Extension of the SAEM algorithm for nonlinear mixed models with 2 levels of random effects Assessment of actual significance levels for covariate effects in NONMEM, Biostatistics . J Pharmacokinet Pharmacodyn, vol.10, issue.28, pp.121-135, 2009. ,
Application of resampling techniques to estimate exact significance levels for covariate selection during nonlinear mixed effects model building: some inferences, Pharmaceutical Research, vol.19, issue.1, pp.92-98, 2002. ,
DOI : 10.1023/A:1013615701857
Covariate Detection in Population Pharmacokinetics Using Partially Linear Mixed Effects Models, Pharmaceutical Research, vol.40, issue.4, pp.541-549, 2005. ,
DOI : 10.1007/s11095-005-2492-z
EVALUATION OF TESTS BASED ON INDIVIDUAL VERSUS POPULATION MODELING TO COMPARE DISSOLUTION CURVES, Journal of Biopharmaceutical Statistics, vol.11, issue.3, pp.107-123, 2001. ,
DOI : 10.1081/BIP-100107652
Evaluation by simulation of tests based on non-linear mixed-effects models in pharmacokinetic interaction and bioequivalence cross-over trials, Statistics in Medicine, vol.83, issue.10 ,
DOI : 10.1002/sim.2047
Some Theorems on Quadratic Forms Applied in the Study of Analysis of Variance Problems, I. Effect of Inequality of Variance in the One-Way Classification, The Annals of Mathematical Statistics, vol.25, issue.2, pp.290-302, 1954. ,
DOI : 10.1214/aoms/1177728786
Weinberg and language impediments, Genetics, vol.152, pp.821-825, 1999. ,
Impact of modelling intra-subject variability on tests based on non-linear mixed-effects models in cross-over pharmacokinetic trials with application to the interaction of tenofovir on atazanavir in HIV patients, Statistics in Medicine, vol.13, issue.6, pp.1268-1284, 2007. ,
DOI : 10.1002/sim.2622
URL : https://hal.archives-ouvertes.fr/inserm-00157143
Evaluation of Uncertainty Parameters Estimated by Different Population PK Software and Methods, Journal of Pharmacokinetics and Pharmacodynamics, vol.21, issue.3, pp.289-311, 2007. ,
DOI : 10.1007/s10928-006-9046-9
Maximum likelihood estimation in nonlinear mixed effects models, Computational Statistics & Data Analysis, vol.49, issue.4, pp.1020-1058, 2005. ,
DOI : 10.1016/j.csda.2004.07.002
Evaluation of hypothesis testing for comparing two populations using NONMEM analysis, Journal of Pharmacokinetics and Biopharmaceutics, vol.69, issue.3, pp.295-313, 1992. ,
DOI : 10.1007/BF01062529
Design and power of a population pharmacokinetic study, Pharmaceutical Research, vol.18, issue.1, pp.75-82, 2001. ,
DOI : 10.1023/A:1011030827847
Bootstrap and Monte Carlo Methods in Biology, 1998. ,
Estimation of Denominator Degrees of Freedom of F-Distributions for Assessing Wald Statistics for Fixed-Effect Factors in Unbalanced Mixed Models, Biometrics, vol.54, issue.3, pp.1085-1096, 1998. ,
DOI : 10.2307/2533859
Inter-and intra-patient variabilities in nevirapine plasma concentrations in HIV-infected cambodian patients and the effect of CYP2B6 genetic polymorphism: ANRS 12154 study, 16th Conference on Retroviruses and Opportunistic Infections Montreal, 2009. ,
The Structure of Haplotype Blocks in the Human Genome, Science, vol.296, issue.5576, pp.2225-2229, 2002. ,
DOI : 10.1126/science.1069424
Simultaneous vs. Sequential Analysis for Population PK/PD Data I: Best-Case Performance, Journal of Pharmacokinetics and Pharmacodynamics, vol.30, issue.6, pp.387-404, 2003. ,
DOI : 10.1023/B:JOPA.0000012998.04442.1f